|
Volumn 13, Issue 2, 2006, Pages 352-353
|
Apaf-1 expression in malignant melanoma [3]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
APOPTOTIC PROTEASE ACTIVATING FACTOR 1;
CISPLATIN;
DOXORUBICIN;
ETOPOSIDE;
FLUOROURACIL;
VINBLASTINE;
APOPTOSIS;
CANCER CELL CULTURE;
CANCER GROWTH;
CANCER SURVIVAL;
CELL SURVIVAL;
DRUG RESPONSE;
GENE EXPRESSION;
GENE MUTATION;
HUMAN;
IN SITU HYBRIDIZATION;
IN VITRO STUDY;
LETTER;
MELANOMA;
NORTHERN BLOTTING;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
APOPTOSIS;
APOPTOTIC PROTEASE-ACTIVATING FACTOR 1;
CELL LINE, TUMOR;
DOWN-REGULATION;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS;
MELANOMA;
PROTEINS;
SAMPLE SIZE;
TIME FACTORS;
TUMOR SUPPRESSOR PROTEINS;
|
EID: 30844456225
PISSN: 13509047
EISSN: 14765403
Source Type: Journal
DOI: 10.1038/sj.cdd.4401755 Document Type: Letter |
Times cited : (19)
|
References (26)
|